These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study. Tan HK; James PD; Wong F Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451 [TBL] [Abstract][Full Text] [Related]
30. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis. Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521 [TBL] [Abstract][Full Text] [Related]
31. Ascites in cirrhosis: a review of management and complications. Kuiper JJ; van Buuren HR; de Man RA Neth J Med; 2007 Sep; 65(8):283-8. PubMed ID: 17890787 [TBL] [Abstract][Full Text] [Related]
32. Cost Effectiveness of Early Insertion of Transjugular Intrahepatic Portosystemic Shunts for Recurrent Ascites. Shen NT; Schneider Y; Congly SE; Rosenblatt RE; Namn Y; Fortune BE; Jesudian A; Brown RS Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1503-1510.e3. PubMed ID: 29609068 [TBL] [Abstract][Full Text] [Related]
33. Refractory Ascites: Pathogenesis, Clinical Impact, and Management. Siqueira F; Kelly T; Saab S Gastroenterol Hepatol (N Y); 2009 Sep; 5(9):647-656. PubMed ID: 37967427 [TBL] [Abstract][Full Text] [Related]
34. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo. Fernández-Esparrach G; Guevara M; Sort P; Pardo A; Jiménez W; Ginès P; Planas R; Lebrec D; Geuvel A; Elewaut A; Adler M; Arroyo V J Hepatol; 1997 Mar; 26(3):614-20. PubMed ID: 9075669 [TBL] [Abstract][Full Text] [Related]
35. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites. Garcia-Tsao G Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501 [TBL] [Abstract][Full Text] [Related]
36. Treatment of ascites: old and new remedies. Inturri P; Graziotto A; Rossaro L Dig Dis; 1996; 14(3):145-56. PubMed ID: 8861522 [TBL] [Abstract][Full Text] [Related]
39. Management of ascites and hepatorenal syndrome. Piano S; Tonon M; Angeli P Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115 [TBL] [Abstract][Full Text] [Related]
40. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt. Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]